Search Results - "Silvis, J M"
-
1
Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein
Published in PloS one (31-08-2020)“…Aims Inflammation plays a pivotal role in atherothrombosis. Colchicine is an anti-inflammatory drug that may attenuate this process. Cardiovascular protective…”
Get full text
Journal Article -
2
Extracellular Vesicle cystatin c is associated with unstable angina in troponin negative patients with acute chest pain
Published in PloS one (05-08-2020)“…Despite the use of high-sensitive cardiac troponin there remains a group of high-sensitive cardiac troponin negative patients with unstable angina with a…”
Get full text
Journal Article -
3
High levels of osteoprotegerin are associated with coronary artery calcification in patients suspected of a chronic coronary syndrome
Published in Scientific reports (23-09-2021)“…Plasma osteoprotegerin (OPG) and vascular smooth muscle cell (VSMC) derived extracellular vesicles (EVs) are important regulators in the process of vascular…”
Get full text
Journal Article -
4
Plasma extracellular vesicle proteins are associated with stress-induced myocardial ischemia in women presenting with chest pain
Published in Scientific reports (23-07-2020)“…Diagnosing stable ischemic heart disease (IHD) is challenging, especially in females. Currently, no blood test is available. Plasma extracellular vesicles (EV)…”
Get full text
Journal Article -
5
S/WAVES: The Radio and Plasma Wave Investigation on the STEREO Mission
Published in Space science reviews (01-04-2008)“…This paper introduces and describes the radio and plasma wave investigation on the STEREO Mission: STEREO/WAVES or S/WAVES. The S/WAVES instrument includes a…”
Get full text
Journal Article -
6
Targeting residual inflammatory risk in coronary disease: to catch a monkey by its tail
Published in Netherlands heart journal (01-01-2022)“…Patients with coronary disease remain at high risk for future cardiovascular events, even with optimal risk factor modification, lipid-lowering drugs and…”
Get full text
Journal Article -
7
The Coronary Sinus Reducer; 5-year Dutch experience
Published in Netherlands heart journal (01-04-2021)“…Background Refractory angina is a growing and major health-care problem affecting millions of patients with coronary artery disease worldwide. The Coronary…”
Get full text
Journal Article -
8
Experimental parameters and infarct size in closed chest pig LAD ischemia reperfusion models; lessons learned
Published in BMC cardiovascular disorders (12-04-2021)“…Preclinical models that resemble the clinical setting as closely as possible are essential in translating promising therapies for the treatment of acute…”
Get full text
Journal Article -
9
Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction
Published in Journal of cardiovascular translational research (01-02-2021)“…Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity worldwide. Atherosclerosis is responsible for the majority of cardiovascular…”
Get full text
Journal Article -
10
Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success
Published in Frontiers in immunology (08-12-2020)“…In the setting of myocardial infarction (MI), ischemia reperfusion injury (IRI) occurs due to occlusion (ischemia) and subsequent re-establishment of blood…”
Get full text
Journal Article -
11
NLRP3-Inflammasome Inhibition with IZD334 Does Not Reduce Cardiac Damage in a Pig Model of Myocardial Infarction
Published in Biomedicines (28-11-2022)“…NLRP3-inflammasome-mediated signaling is thought to significantly contribute to the extent of myocardial damage after myocardial infarction (MI). The purpose…”
Get full text
Journal Article -
12
Extracellular Vesicles in Diagnosing Chronic Coronary Syndromes the Bumpy Road to Clinical Implementation
Published in International journal of molecular sciences (30-11-2020)“…Coronary artery disease (CAD), comprising both acute coronary syndromes (ACS) and chronic coronary syndromes (CCS), remains one of the most important killers…”
Get full text
Journal Article -
13
Neutral Effects of Combined Treatment With GLP-1R Agonist Exenatide and MR Antagonist Potassium Canrenoate on Cardiac Function in Porcine and Murine Chronic Heart Failure Models
Published in Frontiers in pharmacology (26-07-2021)“…Background: Ischemia-reperfusion and cardiac remodeling is associated with cardiomyocyte death, excessive fibrosis formation, and functional decline,…”
Get full text
Journal Article -
14
Staphylococcus lugdunensis infective endocarditis with perforation of the sinus of Valsalva: a case report
Published in European heart journal : case reports (01-04-2023)“…Abstract Background Staphylococcus lugdunensis endocarditis is a rare but fulminant disease. Case summary A 74-year-old female with a history of asymptomatic…”
Get full text
Journal Article -
15
Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy
Published in Circulation (New York, N.Y.) (17-11-2020)Get full text
Journal Article -
16
Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy
Published in Atherosclerosis (01-10-2021)“…Colchicine reduces the risk of cardiovascular events in patients with coronary disease. Colchicine has broad anti-inflammatory effects and part of the…”
Get full text
Journal Article -
17
Safety and efficacy of coronary sinus narrowing in chronic refractory angina: Insights from the RESOURCE study
Published in International journal of cardiology (15-08-2021)“…Refractory angina (RA) is considered the end-stage of coronary artery disease, and often has no interventional treatment options. Coronary sinus Reducer (CSR)…”
Get full text
Journal Article -
18
The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial
Published in Clinical drug investigation (01-11-2022)“…Background and Objective The Low-Dose Colchicine-2 (LoDoCo2) trial showed that 2–4 years exposure to colchicine 0.5 mg once daily reduced the risk of…”
Get full text
Journal Article -
19
End-of-trial inflammatory biomarkers, lipid levels, creatine kinase and markers of renal and liver function in the LoDoCo2 trial
Published in European heart journal (03-10-2022)“…Abstract Background The Low-Dose Colchicine 2 (LoDoCo2) trial demonstrated that colchicine reduced major cardiovascular events in patients with chronic…”
Get full text
Journal Article -
20
Staphylococcus lugdunensis infective endocarditis with perforation of the sinus of Valsalva: a case report
Published in European heart journal. Case reports (01-04-2023)“…BackgroundStaphylococcus lugdunensis endocarditis is a rare but fulminant disease. Case summaryA 74-year-old female with a history of asymptomatic severe…”
Get full text
Report